Headache and Migraine

The NeurologyLive^® headache and migraine clinical focus page offers information, podcasts, videos, and news and interviews with physicians related to the care of patients with headache disorders such as chronic and episodic migraine, cluster headache, tension-type headache, and more. The page includes updates on the latest FDA actions, clinical guidelines, and study and clinical trial findings.

Check out some of NeurologyLive^®'s featured content in the carousel below.

Episode 67: Mental Health and Advocacy in Pediatric Migraine

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Serena L. Orr, MD, MSc.

Optimal Management of Acute and Preventive Migraine

Expert neurologists share expert approaches to the diagnosis and treatment of acute and preventive migraine and discuss key insights on the evolving treatment landscape.

NeuroVoices: Anne Kelly, MD, on Evaluating and Improving Care for Migraine in the ED

The director of the Joseph Epstein Center for Emergency Medicine Research provided context on a study that showed wide variation in EDs diagnosis, treatment, and management of headache.

NeurologyLive® Brain Games: November 27, 2022

November 27, 2022

Article

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is sleep disorders.

NeurologyLive® Friday 5 — November 25, 2022

November 25, 2022

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 25, 2022.

This Week on NeurologyLive® — November 21, 2022

November 21, 2022

Article

Here's some of what is coming soon to NeurologyLive® this week.

NeurologyLive® Brain Games: November 20, 2022

November 20, 2022

Article

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neuromuscular disorders.

Positive Results of STK-001 in Dravet, Zavegepant Meets Primary End Points, FDA Accepts NDA of Zilucoplan for Myasthenia Gravis

November 19, 2022

Video

Neurology News Network for the week ending November 19, 2022. [WATCH TIME: 3 minutes]

NeurologyLive® Friday 5 — November 18, 2022

November 18, 2022

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 18, 2022.

Headache Identified as Common Symptom in COVID-19 Variants, Mainly Delta

November 16, 2022

Article

Six months after hospital discharge, COVD-19 headache was more frequently observed in those infected with the Delta variant vs Wuhan or Alpha variants.

Gore Explores Migraine Treatment Using Patent Foramen Ovale Closure in New Study

November 15, 2022

Article

The newly announced prospective, randomized, placebo- and sham-controlled study, will include 150 patients, ages 18 to 55 years, with documented patent foramen ovale and a history of more than 1 migraine headache day per week.

Phase 2/3 Results of Zavegepant Showcase Effectiveness as Acute Migraine Medication

November 15, 2022

Article

Evidence of therapeutic benefit for zavegepant was observed on multiple secondary end points, including return to normal function at 30 min postdose, sustained pain relief, and sustained pain freedom.

This Week on NeurologyLive® — November 14, 2022

November 14, 2022

Article

Here's some of what is coming soon to NeurologyLive® this week.

Latest News

NeurologyLive® Brain Games: November 27, 2022

Treating NMOSD Early in the Disease Course: Inebilizumab’s Efficacy in N-MOmentum

Aquatic Therapy Improves MS Fatigue, MS Disease Pathology Not Defined by Courses, Rituximab Shows Positive Effect in Myasthenia Gravis

NeurologyLive® Friday 5 — November 25, 2022

View More News